Fig. 2From: Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinomaGO enrichment and KEGG pathway analysis of CDK1-4, 6. GO analysis (A); KEGG pathway analysis (B)Back to article page